India Glucometer Market Size By Product (Self-Monitoring Blood Glucose System, Continuous Glucose Monitoring Devices), By Technique (Invasive accounted), By End-User (Homecare, Hospitals/Institutional/Diagnostics), Scope And Forecast

India Glucometer Market Size And Forecast

India Glucometer Market size was valued at USD 176.14 Million in 2023 and is projected to reach USD 367.31 Million by 2030, at a CAGR of 9.94% from 2023 to 2030.

Rising prevalence of diabetes in India and growth of the aging population in India are the factors driving market growth. The India Glucometer Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

India Glucometer Market Definition

Glucometers, also known as blood glucose meters or glucose monitors, are portable medical devices designed to measure and monitor the concentration of glucose (sugar) in a person’s blood. These devices are commonly used by individuals with diabetes to keep track of their blood glucose levels, helping them manage their condition effectively. Glucometers typically consist of a small handheld unit with a digital display and a lancet device for pricking the skin to obtain a small blood sample. The user places a drop of blood on a test strip, which is then inserted into the glucometer. The device analyzes the blood sample and provides a numerical reading of the blood glucose level, usually in milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L). Regular monitoring of blood glucose levels with a glucometer is crucial for people with diabetes to make informed decisions about their diet, medication, and lifestyle to maintain optimal blood sugar control.

Glucometers, or glucose monitoring devices, can be categorized based on various factors such as the product type, technique, and end users. Continuous Glucose Monitoring (CGM) Devices are devices that continuously monitor blood glucose levels throughout the day and night, providing real-time data. CGMs consist of a sensor that is inserted under the skin, a transmitter, and a receiver or smartphone app to display and analyze the data. CGMs are useful for individuals who need frequent and continuous monitoring, such as those with type 1 diabetes or those looking for a comprehensive understanding of their blood glucose trends.

Self-Monitoring Blood Glucose (SMBG) devices, commonly known as traditional glucometers, are portable devices that allow individuals to manually measure their blood glucose levels at specific times throughout the day. Users typically prick their finger to obtain a blood sample, which is then placed on a test strip and analyzed by the meter. Self-Monitoring Blood Glucose systems is commonly used by people with diabetes for routine blood glucose monitoring.

The choice of glucometer product, technique, and end user can vary depending on the individual’s needs, the healthcare setting, and the specific requirements of diabetes management. Continuous advancements in glucometer technology continue to improve the accuracy and convenience of blood glucose monitoring for individuals with diabetes and healthcare professionals.

India Glucometer Market Overview

The escalating prevalence of diabetes in India is unquestionably driving a surge in demand for glucometers within the country. Diabetes has reached alarming levels in India, with millions of individuals grappling with this condition. This health trend has led to a substantial increase in the demand for tools designed to manage and monitor blood glucose levels. India is often characterized as the “diabetes capital of the world” due to the sheer magnitude of people affected by this disease.

The recent study published in Lancet highlights the concerning prevalence of diabetes in India, impacting a staggering 101 million individuals, representing 11.4% of the nation’s population. This study draws attention to the significant and growing burden of diabetes on India’s healthcare landscape. Several factors converge to contribute to the heightened vulnerability of adults to diabetes in recent times. Sedentary lifestyles, unhealthy dietary habits, obesity, elevated stress levels, and genetic predispositions all play pivotal roles in the escalating diabetes epidemic in the country.

The growth of the aging population in India is significantly increasing the demand for glucometers. India, like many other countries, is undergoing a demographic shift marked by a larger proportion of elderly individuals. According to the National Diabetes and Diabetic Retinopathy Survey report released by the health and family welfare ministry, the highest prevalence of diabetes was observed in the 70-79 years age group, with a rate of 13.2%. This finding underscores the age-related nature of diabetes prevalence and the importance of tailored healthcare and diabetes management strategies for different age groups.

The financial constraints experienced by healthcare providers, including hospitals and clinics, exacerbate the problem. The high cost of glucometers can dissuade these healthcare facilities from investing in the necessary equipment, ultimately constricting access to comprehensive diabetes care for their patients. In rural and underserved areas of India, where access to healthcare services and resources is already limited, the situation is even more challenging. High-cost glucometers are less likely to be available or affordable in these regions, leaving individuals with fewer options for effectively managing their diabetes.

With the bolstering of healthcare infrastructure, more individuals in India now enjoy improved access to healthcare services, including the diagnosis and management of chronic conditions like diabetes. This expanded access has led to an increasing number of people seeking medical care, consequently driving up the demand for glucose monitoring devices. Improved healthcare infrastructure often goes hand in hand with heightened awareness and education about chronic diseases, with a particular focus on diabetes. Healthcare providers and public health campaigns are actively engaging in educating the population about the significance of regular blood glucose monitoring for early detection and effective management of diabetes. This heightened awareness has translated into a greater demand for glucose monitoring devices.

India Glucometer MarketSegmentation Analysis

The India Glucometer Market is segmented on the basis of Product, Technique, and End-User.

India Glucometer Market, By Product

• Self-Monitoring Blood Glucose System
• Continuous Glucose Monitoring Devices

To Get a Summarized Market Report By Product-

Based on Product, the market is segmented into Self-Monitoring Blood Glucose System and Continuous Glucose Monitoring Devices. Self-Monitoring Blood Glucose System accounted for the largest market share in 2022 and is projected to grow at a CAGR of 9.84% during the forecast period. Self-Monitoring Blood Glucose System (SMBG) is a method of testing blood glucose levels at home or anyplace using a portable device called a glucometer. SMBG assists diabetics in regularly monitoring their blood sugar levels and adjusting their diet, exercise, and medication accordingly. SMBG also helps to prevent or detect hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) and lowers the risk of diabetes complications. These devices are mainly classified into two typesglucose meters and glucose test strips. Glucose meters are portable devices that measure the level of glucose in the blood from a little drop of blood acquired by pricking the finger or other body areas. Glucose test strips are disposable strips that contain chemicals that react with the glucose in the blood, producing a color change or an electrical signal that the meter can interpret.

India Glucometer Market, By Technique

• Invasive accounted
• Non-Invasive accounted

Based on Technique, the market is segmented into Invasive accounted for the largest market share in 2022 and is projected to grow at a CAGR of 9.80% during the forecast period. An invasive technique is a method of testing blood glucose levels that involves drawing blood from the body, usually by pricking the finger or other body parts with a lancet. The blood sample is then put to a glucose test strip, which includes chemicals that react with glucose, producing a color change or an electrical signal that a glucose meter can interpret. The glucose meter either displays the blood glucose level on a screen or transmits it to a smartphone app or a cloud-based platform. In India and across the globe, the invasive technique is the most popular and widely utilized form of glucose monitoring. It is regarded as the gold standard for glucose measuring precision and dependability. It is also recommended by the American diabetic Association, the International Diabetes Federation, the Indian Council of Medical Research, and the Research Society for the Study of Diabetes in India for diabetic management.

India Glucometer Market, By End-User

• Homecare
• Hospitals/Institutional/Diagnostics

To Get a Summarized Market Report By End-User-

Based on End-User, the market is segmented into, Homecare and Hospitals/Institutional/Diagnostics. Homecare accounted for the largest market share in 2022 and is projected to grow at a CAGR of 9.37% during the forecast period. Homecare is one of the major end users of glucometers in India, as it refers to the use of glucometers and related items by individuals with diabetes at their homes or other personal settings. Homecare is a significant and growing segment of the India glucometer market, driven by factors such as rising demand for convenient and affordable glucose monitoring devices, rising awareness and adoption of self-monitoring blood glucose (SMBG) among patients and healthcare professionals, technological advancements and innovations in glucometer devices and strips, and supportive government policies and initiatives for diabetes management.

Key Players

The “India Glucometer Market” study report will provide valuable insight with an emphasis on the global market including some of the major players are Roche India Pvt Ltd, Morepen Laboratories Ltd, Lifescan India, Ascensia Diabetes Care, SD Biosensor Healthcare Pvt Ltd, MicroGene Diagnostic Systems (P) Ltd, Abbott India, Arkray Healthcare Pvt Ltd, Q-Line Biotech Pvt Ltd, Neureca Limited (Dr. Trust), Vertech HealthSolutions India Pvt. Ltd.(Diabascan), Control D Home Healthcare., I- Sens Biosensors India Pvt. Ltd, Sensacore Medical Instrumentation.This section provides a company overview, ranking analysis, company regional and industry footprint, and ACE Matrix.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with Coating Type benchmarking and SWOT analysis.

Key Developments

• In May 2023, Accu Roche Diabetes Care India (Roche) announced that its top-selling blood glucose monitoring device ‘Accu-Chek Active’ is now made in India, as part of company’s strategy to improve access to diabetes care and meet the growing needs of the Indian market.

Report Scope

Top Trending Reports